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Gloviczki, MD, Rochester, Minn
Endovenous techniques such as radiofrequency ablation (RFA) and endovenous laser therapy (ELT) have emerged as
percutaneous minimally invasive procedures for ablation of incompetent great saphenous veins in patients with varicosity
and venous insufficiency. Early reports showed safety and efficacy of both techniques, with excellent technical success rates
and few major complications, such as deep vein thrombosis or pulmonary embolism. During our initial experience with
ELT in 56 limbs of 41 patients, 39 underwent postoperative duplex scanning. We encountered three cases (7.7%) with
thrombus extension into the common femoral vein. All three patients were anticoagulated, and a temporary inferior vena
cava filter was placed in one. All remained asymptomatic. The thrombus resolved by 1 month in all three patients. Review
of the literature revealed that the incidence of thrombus extension into the common femoral vein or deep vein thrombosis
in published clinical series is 0.3% after ELT and 2.1% after RFA. This possibility warrants routine postoperative duplex
scanning, more alertness during these procedures, and patient education on this possible complication. (J Vasc Surg
2005;41:130-5.)Until recently, high ligation and surgical stripping of
the great saphenous vein (GSV), usually from the groin to
the knee, has been the treatment of choice for GSV incom-
petence associated with varicose veins and chronic venous
insufficiency. In recent years, percutaneous minimally inva-
sive endovenous techniques such as radiofrequency abla-
tion (RFA) (Closure procedure; VNUS Medical Technol-
ogies Inc, San Jose, Calif) and endovenous laser therapy
(ELT) have emerged and are used with increasing fre-
quency for ablation of incompetent GSV. Early reports
have claimed safety and efficacy of both procedures, with
initial technical success in more than 95% of patients.
Short-term clinical benefit with sustained occlusion of the
GSV and freedom from reflux at 2 years has been reported
in 95% to 97% of patients. These procedures have already
replaced standard surgical stripping as the therapy of choice
for many patients undergoing GSV ablation. Major com-
plications such as deep vein thrombosis (DVT) and pulmo-
nary embolism (PE) have been reported to be relatively rare
with these techniques.1
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Since the introduction of ELT, 56 limbs in 41 patients (76%
female; age, 51.6 13 years [mean SD]) were treated with this
technique at our institution between July 14, 2003, and February
3, 2004. Indications were symptomatic lower extremity varicose
veins (class 2-4) in 54 (96%) limbs and advanced chronic venous
insufficiency (class 5-6) in 2 (4%) limbs. Etiology was primary in 53
limbs (95%) and secondary in 3 limbs (5%). GSV ELT was com-
bined with surgical varicectomy (n  54; 96%), stripping of the
small saphenous vein (n 2; 4%), and additional ELT of an accessory
GSV in one limb. The operations were performed under general or
spinal anesthesia supplemented with local tumescent anesthesia. The
810-nm diode laser was used, and the GSV from just distal to the
inferior epigastric vein to the kneewas treated. All 56 procedures were
successfully completed. Forty-five (80%) limbs in 32 patients have
been followed up clinically; duplex ultrasonography (DUS) was per-
formed 1 week after surgery in 39 limbs. None of the followed limbs
had clinical evidence of DVT, and no patient presented with PE.
In 3 (7.7%) of the 39 limbs imaged after surgery, we encoun-
tered a thrombus in the proximal GSV extending through the
saphenofemoral junction (SFJ) to involve the common femoral
vein (CFV). All three patients had primary varicose veins and were
treated with GSVELT and stab avulsion of branch varicosities. The
length of GSV treated and the energy applied in each case are
presented in Table I. Analyzing the relationship between case
sequence and thrombus extension, we found that the 3 cases were
No. 36 and 41 for one surgeon who performed 43 cases and No. 4
for a second surgeon who performed 12 cases. A third surgeon
with one case did not have complications. Overall, they were cases
19, 48, and 54 of our cases.
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right GSV. At the routine 1-week follow-up, DUS showed a small
knuckle of thrombus protruding into the CFV at the SFJ, reducing
the lumen of the CFV by approximately 30% (Fig 1, A). Antico-
agulation with low-molecular-weight heparin and warfarin was
Table I. Length of great saphenous vein (GSV) treated
with endovenous laser therapy and the amount of energy
applied in cases complicated by extension of thrombus
into the common femoral vein
Case No.
Length of
GSV treated
(cm)
Laser
energy
(J/cm)
Laser
energy
(J/s)
Total laser
energy
(J)
1 30 50 17 1500
2 30 50 17 1500
3 32 56 19 1800
Fig 1. A, One week after treatment, thrombus (arrowhead) ap-
pears to protrude from the great saphenous vein (GSV) into the
common femoral vein (CFV). B, Three months later, the throm-
bus is no longer visible.started. The patient remained asymptomatic, and repeat DUS in 1week showed no change, but follow-up DUS at 3 months showed
complete resolution (Fig 1, B).
Case 2. A 51-year-old woman was treated with ELT of the
left GSV. One week later routine follow-up, DUS revealed throm-
bus protruding into the CFV for 2 cm above the SFJ (Fig 2, A).
She was started on low-molecular-weight heparin and warfarin.
One week later, interval resolution of the CFV thrombus was
noted, and anticoagulation was continued for three more weeks
(Fig 2, B). She remained asymptomatic.
Case 3. A 75-year-old woman was treated with left GSV
ELT. On routine DUS at 1 week, there was a thrombus at the left
SFJ, which extended into the CFV and partially obstructed the
lumen for 1 to 1.5 cm. The thrombus appeared to be attached to
the SFJ but not to the wall of the CFV (Fig 3, A). She was
anticoagulated, and a temporary inferior vena cava filter was
placed. Two weeks later, DUS confirmed complete resolution of
the CFV thrombus; therefore, the filter was removed (Fig 3, B).
No thrombus was identified in the filter. She remained asymptom-
atic, completed 3 months of Coumadin treatment, and was lost to
further follow-up.
DISCUSSION
DVT has been rarely reported after surgical treatment
of lower extremity varicosity; therefore, DVT prophylaxis
routinely has been limited to early mobilization and com-
pressive stockings. Subcutaneous heparin has been used
only for high-risk patients.2,3 The surgical technique of
GSV stripping includes its flush ligation with the CFV to
avoid a cul-de-sac providing a nidus for proximal thrombus
propagation. Although flush ligation can easily be accom-
plished with an open technique, the concept is compro-
mised during endovenous therapy. The potential for
thrombus extension is therefore real, because most tech-
niques recommend leaving the upper 1 or 2 cm of the GSV
open to avoid occlusion of the groin collaterals and to
maintain patency of the SFJ. Only very few investigators
suggest flush occlusion of the saphenous vein with the
femoral vein during these procedures (R. J. Min, Cornell
University, New York, personal communication, 2003).
The immediate fate of the lumen of the GSV after
endovenous therapy is unclear. Min et al4 suggested that
swelling of the injured venous wall obliterates the lumen
after ELT. Others, however, found that GSV occlusion is a
thrombotic process associated with an increase in the level
of circulating D-dimer.5 Explanation for this controversy
may be related to the differences in wavelength (940- vs
810-nm diode laser) and the amount of laser energy applied
in these studies. Intuitively, acute thrombosis of the GSV
could easily predispose for femoral DVT by propagation
through the SFJ.
Despite these concerns, Min et al,4 who reported the
largest series on ELT, from Cornell University, encoun-
tered no DVT in 499 limbs. Only one DVT was found in
the literature among studies reporting on ELT of GSV
insufficiency (Table II).4,6-12When we looked on the Food
and Drug Administration Web site for adverse reactions
and searched for “Dornier MedTech” and “Diomed,” we
were able to find only one case in which a small nonocclu-
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vein after ELT with the Diomed device (Diomed Inc,
Andover, Mass).13 No reports were found for Dornier
(Dornier MedTech America, Kennesaw, Ga).
Differences in finding thrombus extension after ELT,
Fig 2. A, Axial scan of the inguinal region showing th
(CFA). In the left picture, the vein is partially filled by ec
compression with the probe was not able to produce vein
was no filling defect in the vein, which collapsed (arrowh
region.
Table II. Thromboembolic complications reported in clin
First author, year
Wavelength of
laser (nm)
No. Limbs/No
Patients
Navarro,6 2001 810 40/33
Gerard,7 2002 980 20/20
Chang,8 2002 1064 252/149
Min,4 2003 810 504/423
Proebstle,9 2003 940 109/85
Oh,10 2003 980 15/12
Perkowski,11 2004 940 203/165
Timperman,12 2004 810-940 111/87
Mayo Clinic, 2004 810 56/41
Articles that seemed to report on the same series of patients were excluded.
DUS, Duplex ultrasonography; DVT, deep vein thrombosis; PE, pulmonary
*Patients received prophylactic postoperative low-molecular-weight heparinin our experiences and those reported by Min et al,4 can beexplained by the technique we used. We prefer to perform
ELT under general, spinal, or epidural anesthesia supple-
mented by tumescent local anesthesia, and we always com-
bine saphenous ablation with stab phlebectomy. The Cor-
nell group uses only tumescent local anesthesia for ELT and
mon femoral vein (CFV) and common femoral artery
ic material (arrowhead). In the right picture, maximum
pse.B,One week later, as shown in the left picture, there
the right picture) as the probe compressed the inguinal
series of endovenous laser therapy
Limbs
followed up
with DUS
Timing of DUS
follow-up DVT PE
40 1 and 7 d 0 0
20 3 and 8 d 0 0
252 Not reported 0 0
499 1 wk 0 0
104 1 and 8 d 0* 0*
15 1 wk 0 0
203 2 wk 0 0
111 1 wk 1 0
39 1 wk 3 0
olism.e com
hogen
colla
ead inical
.
embapplies delayed sclerotherapy during follow-up to eliminate
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comitant varicectomy can increase the period of immobili-
zation; however, historically they have not resulted in such
high rates of DVT after stripping of the GSV.2,3 The
amount of laser energy delivered and the size and disten-
sion of the vein with bloodmay influence the relative extent
of destruction of the vein wall. The number of patients
treated in this early phase of our experience is too small to
assess all of these variables. It is also difficult to directly
correlate our higher thrombus extension rate with a learn-
ing curve, because these events were sporadic during our
early experience. However, the high rate of DVT in this
small series suggests that the exemplary results of pioneers
in ELT technology may not be easily reproducible.
Currently, there is no agreement regarding whether the
first 1 to 2 cm of the GSV should be treated during
endovenous laser ablation. We start GSV ablation at 1 cm
distal to the confluence of the inferior epigastric vein and
the GSV. Regardless of the distance considered appropriate
for the proximal end point of treatment, ultrasonographic
visualization of the SFJ can never be compromised. This, in
our experience, permits continued patency of the SFJ, and
flow from the inferior epigastric vein prevents extension of
the saphenous thrombus. In addition, leg elevation during
treatment decreases the blood in the saphenous vein and
aids in minimizing the thrombus load in the occluded
saphenous vein.
The VNUS Closure procedure is associated with a
presumably higher incidence of thromboembolic compli-
cations (Table III). Twenty-one cases of DVT and 2 of PE
have been reported in 11 previous articles.15-25 A recent
series of 66 patients treated with VNUS Closure reported a
16% incidence of DVT.25 All but one were described as
thrombus extension into the CFV. No association of the
DVT episodes with the type of anesthesia, postoperative
mobilization, age, sex, or associated vein procedures was
found.
Searching the Food and Drug Administration Web site
for “VNUS” and “Closure,” we found reports of 24 DVT
episodes and 3 PE episodes.26 Some of these reports,
however, may refer to the same patients, thus making it
difficult to calculate the absolute number of thrombotic
events. In many series of RFA, the postoperative duplex
follow-up scanning is incomplete; therefore, the exact inci-
dence of asymptomatic DVT is unknown. With these lim-
itations in mind, we estimate that the cumulative incidence
of DVT and PE after the VNUS Closure procedure is 2.1%
and 0.2%, respectively (Table III). Expert authors, how-
ever, report lower incidences: in a cumulative series from
Merchant et al,1 there were 5 episodes of DVT among
1150 procedures (0.4%), with no PE.
The incidence of DVT after GSV stripping is not well
known. Historically, Lofgren et al27 reported 16 cases of
suspected PE among more than 4000 operations for vari-
cose veins at the Mayo Clinic. In a more recent study, 3
(0.6%) symptomatic DVT cases were reported after 544
procedures.28 Surprisingly, a prospective study with ultra-
sonography follow-up showed 20 (5.7%) DVT incidents in377 patients (494 limbs) who underwent varicose vein
Fig 3. A, Longitudinal scan of the saphenofemoral junction
showing the presence of thrombus in the common femoral vein
(CFV) (arrows). B, Two weeks later, there was no color-filling
defect in the CFV. The great saphenous vein (GSV) appears to be
regularly occluded up to the superficial epigastric vein.surgery.29 Most DVT was asymptomatic (12/20) and lo-
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was found among patients who received pharmacologic
prophylaxis.
In both ELT and radiofrequency series, DVT is often
described as an extension of the thrombus from the SFJ
into the CFV. This presentation is worrisome because of
the proximal location and the direct correlation with the
procedure undertaken. The different patterns of presenta-
tion with the aforementioned reported DVTs after GSV
stripping are remarkable.29 In fact, the latter were usually
distal and had a low tendency to propagation. This fact,
together with the lack of association in the article from
Hingorani et al25 of DVT with classic thromboembolic risk
factors, suggests that they might represent two distinct
pathophysiologic entities.
Our experience in 39 patients with 3 cases of thrombus
extension into the femoral vein after ELT, enforced by the
recent articles of Hingorani et al25 and van Rij et al,29
warrants further studies to better understand the postoper-
ative clinical course of GSV treated for incompetence and
the mechanisms underlying postoperative thrombosis. It is
our opinion (based on the available data) that both RFA
and ELT result in an increased risk of CFV thrombosis
when compared with the open procedure. For this reason,
we recommend that a postoperative duplex examination be
performed within 1 week to detect asymptomatic adverse
events. The same recommendation came from a recently
published consensus conference on laser treatment of vari-
cose veins.30
The role for pharmacologic prophylaxis remains uncer-
tain. Because the adverse events are so sporadic, only pro-
spective studies specifically addressing the problem can
answer the question. Until more evidence is available, we
emphasize the importance of early ambulation and com-
pression stockings for patients undergoing endovenous
procedures. Careful attention should be paid to all poten-
tial factors for increased thromboembolic risk, because
Table III. Thromboembolic complications reported in cli
saphenous vein (VNUS Closure procedure)
First author, year
No. Limbs/No.
Patients
Limb
up w
Chandler,15 2000 301/272*
Goldman,16 2002 50/47
Komenaka,17 2002 29 Not
Fassiadis,18 2002 127/79
Merchant,19 2002 318/286
Rautio,20 2002 30/27
Sybrandy,21 2002 26/26
Weiss,22 2002 140/120
Lurie,23 2003 44/44
Wagner,24 2004 28/24
Hingorani,25 2004 73/66
Mayo Clinic, 2004† 51/39
Articles that seemed to report on the same series of patients were excluded.
DUS, Duplex ultrasonography; DVT, deep vein thrombosis; PE, pulmonary
*Including eight small saphenous veins and one accessory saphenous vein.
†Unpublished data.these patients will benefit from drug prophylaxis.In conclusion, the apparent increased risk of early ex-
tension of thrombus or DVT after radiofrequency ablation
and ELT, according to this series and other recent publica-
tions, warrants routine postoperative duplex scanning
within a few days, more alertness during these procedures,
and patient education on the possibility of such complica-
tions. With these precautionary considerations in mind, we
continue to offer ELT as an alternative option to patients
who are suitable candidates for both laser and open surgical
therapy. Prospective randomized studies comparing strip-
ping with new minimally invasive methods are necessary to
determine the exact role for ELT and RFA in the armamen-
tarium of the venous surgeon.
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